Skip to main content

Featured Content

A model of care that is grounded in evidence-based modalities of treatment, which integrates the science of medicine, the art of therapy and the compassion of spirituality into an experience that forges connection to self, others and a sense of meaning and purpose is highly effective in treating persons suffering from substance use disorder.
Preliminary data from researchers at the University of Pittsburgh Medical Center showed that naltrexone reduced both pain and disability in chronic pain patients when administered in low doses, according to a media report.
A study by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy found that 1 in 5 pharmacies refuse to dispense Suboxone, the medication that combines buprenorphine and naloxone.
With funding from a State Opioid Response 2.0 grant, the Ohio Department of Mental Health and Addiction Services will provide access to Pear Therapeutics' reSET and reSET-O digital therapeutics for the treatment of SUD and OUD.
Policies aimed at curbing opioid misuse might be limiting access to pain-relieving medications for terminally ill patients, according to research from Oregon State University.

Meetings & Publications

Back to Top